04.06.23
Global ingredient supplier ADM has announced a partnership with Brightseed, a company specializing in the discovery and development of bioactive ingredients, to develop functional synbiotic products (which contain a beneficial combination of a microbe and a substrate) for the microbiome.
The gut microbiome has been studied as a central component of human health in research spanning the past 15 years, though much remains to be discovered about specific functions of microbial communities, and interactions between diet, microbiome, and host. As a result, there has been a surge of interest in nutrition science covering the role of prebiotics, probiotics, postbiotics, and synbiotics for precision gut health benefits.
Artificial intelligence allows for the discovery of bioactives in plants, and mapping them to specific modes of action, at a greater rate and accuracy than was previously possible.
We know from our recent research into global consumer trends that macro forces, including the lingering pandemic, have coincided with an increased demand for natural and plant-based solutions that target immune function, metabolic health, and mental well-being,” said Mark Lotsch, ADM’s president of global health and wellness. “We are thrilled to partner with Brightseed to lead in state-of-the-art discovery on the microbiome, and to bring forward science-backed solutions that empower consumers toward proactive and individualized health.”
“Brightseed and ADM share the conviction that precision health outcomes for consumers should be driving category innovation,” said Sofia Elizondo, Brightseed’s co-founder and chief operating officer. “ADM's advanced understanding of the untapped potential of natural compounds, combined with their vast microbial libraries, is the sum total expertise that will redefine the future of ingredients to promote a healthy microbiome.”
The gut microbiome has been studied as a central component of human health in research spanning the past 15 years, though much remains to be discovered about specific functions of microbial communities, and interactions between diet, microbiome, and host. As a result, there has been a surge of interest in nutrition science covering the role of prebiotics, probiotics, postbiotics, and synbiotics for precision gut health benefits.
Artificial intelligence allows for the discovery of bioactives in plants, and mapping them to specific modes of action, at a greater rate and accuracy than was previously possible.
AI Bioactive Discovery
The companies will use Forager, Brightseed’s artificial intelligence (AI) program, to analyze molecular interactions between dietary plants and gut microbes, and their potential impact on human health. In late 2022 on its own, Brightseed launched Bio 01, a hemp fiber standardized to contain two bioactive compounds which supported measures of gut barrier integrity in preclinical studies.We know from our recent research into global consumer trends that macro forces, including the lingering pandemic, have coincided with an increased demand for natural and plant-based solutions that target immune function, metabolic health, and mental well-being,” said Mark Lotsch, ADM’s president of global health and wellness. “We are thrilled to partner with Brightseed to lead in state-of-the-art discovery on the microbiome, and to bring forward science-backed solutions that empower consumers toward proactive and individualized health.”
“Brightseed and ADM share the conviction that precision health outcomes for consumers should be driving category innovation,” said Sofia Elizondo, Brightseed’s co-founder and chief operating officer. “ADM's advanced understanding of the untapped potential of natural compounds, combined with their vast microbial libraries, is the sum total expertise that will redefine the future of ingredients to promote a healthy microbiome.”
